bioAffinity Technologies(us:BIAF)
0.9928
-15.86%
Updated on 2024-12-22
Open:1.24
Close:0.9928
High:1.29
Low:0.9820
Pre Close:1.18
Volume:478853.00
Amount:514108.34
Turnover:3.07%
Shares:15.58M
MarketCap:15.47M
About bioAffinity Technologies Company
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Company Name: bioAffinity Technologies
Company Address: 22211 West Interstate 10,Suite 1206
Employees: 75
Fiscar Year: 12-31
IPO Date: 2022-09-01
Website: http://www.bioaffinitytech.com
CIK: 1712762
View all SEC Filings
About
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Address:22211 West Interstate 10,Suite 1206
Website:http://www.bioaffinitytech.com
Market Movers